Norman Leeds, MD, Oral History Interview, May 30, 2017
Files
Download Full Interview Transcript (586 KB)
Loading...
Description
Major Topics Covered:
- Personal background and education; two-career marriage
- Professional trajectory prior to MD Anderson
- Participation in and perspectives on the formative years of neuroradiology
- Research contributions to neuro-radiology Change at MD Anderson
- Views on assuming leadership roles
- Mentoring
Identifier
LeedsN_01_20170530
Publication Date
5-30-2017
Publisher
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Leeds, Norman MD and Rosolowski, Tacey A. PhD, "Norman Leeds, MD, Oral History Interview, May 30, 2017" (2017). Interview Sessions. 155.
https://openworks.mdanderson.org/mchv_interviewsessions/155
Conditions Governing Access
Open
About the Interview
About the Interview Subject:
Dr. Norman Leeds (b. 9 June 1928, West New York, New Jersey) came to MD Anderson in 1991 to serve as Head of the Section of Neuroradiology in the Department of Diagnostic Radiology. He is one of the pioneering founders of the field of neuroradiology and conducted foundational work on brain anatomy, the use of imaging techniques to enhance tumor diagnosis, and the toxic effects of chemotherapy on brain tissue. Dr. Leeds retired in 2003 to emeritus status, but at the time of the interview was continuing to come in to MD Anderson to mentor students and otherwise stay connected to the institution’s research and clinical community.